M. R. Öncü Et Al. , "Use of ABO blood groups and co-morbidities as predictors of mortality in COVID-19 patients," EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.26, no.12, pp.4449-4455, 2022
Öncü, M. R. Et Al. 2022. Use of ABO blood groups and co-morbidities as predictors of mortality in COVID-19 patients. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.26, no.12 , 4449-4455.
Öncü, M. R., Akta, R. S., Gizli, G., Bilvanisi, S., Yildiz, H., & Baran, A., (2022). Use of ABO blood groups and co-morbidities as predictors of mortality in COVID-19 patients. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.26, no.12, 4449-4455.
Öncü, Mehmet Et Al. "Use of ABO blood groups and co-morbidities as predictors of mortality in COVID-19 patients," EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.26, no.12, 4449-4455, 2022
Öncü, Mehmet R. Et Al. "Use of ABO blood groups and co-morbidities as predictors of mortality in COVID-19 patients." EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.26, no.12, pp.4449-4455, 2022
Öncü, M. R. Et Al. (2022) . "Use of ABO blood groups and co-morbidities as predictors of mortality in COVID-19 patients." EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.26, no.12, pp.4449-4455.
@article{article, author={Mehmet Reşit Öncü Et Al. }, title={Use of ABO blood groups and co-morbidities as predictors of mortality in COVID-19 patients}, journal={EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES}, year=2022, pages={4449-4455} }